Endstage Renal Disease

Nephrology
1
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

AbbVie
AbbVieNORTH CHICAGO, IL
1 program
1
Intravenous ParicalcitolPhase 41 trial
Active Trials
NCT03023748Unknown30Est. Jan 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AbbVieIntravenous Paricalcitol

Clinical Trials (1)

Total enrollment: 30 patients across 1 trials

NCT03023748AbbVieIntravenous Paricalcitol

Intravenous Paricalcitol in Chronic Hemodialysis Patients

Start: Sep 2011Est. completion: Jan 201830 patients
Phase 4Unknown

Related Jobs in Nephrology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space